-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-09-14
The reference study identifies ziprasidone as a noncompetitive GOT1 inhibitor that disrupts glutamine metabolism, redox balance, and growth of pancreatic ductal adenocarcinoma cells. Its biochemical, cellular, metabolomic, genetic, and xenograft evidence supports GOT1 as a metabolic vulnerability while leaving questions about selectivity, exposure, and clinical translation.
-
WSP-5 for Live-Cell H2S Imaging
2026-09-14
WSP-5 is a rapid turn-on fluorescent probe for visualizing hydrogen sulfide in living cells and donor-release experiments. This practical guide connects assay setup, diabetic cardiomyopathy findings, controls, and troubleshooting to help researchers convert H2S signals into interpretable biological data.
-
Y-27632 dihydrochloride in Invasion Assays
2026-09-13
Y-27632 dihydrochloride is a selective ROCK inhibitor for dissecting actomyosin-dependent migration and invasion. This article translates breast cancer pathway evidence into practical assay decisions, controls, and interpretation strategies.
-
Direct Mouse Genotyping Kit Plus Workflow Guide
2026-09-12
The Direct Mouse Genotyping Kit Plus enables direct PCR from mouse tissue lysates, helping laboratories accelerate transgene detection, knockout confirmation, and colony decisions. This guide connects a streamlined genotyping workflow with lineage-tracing needs raised by recent Kupffer-cell research, while emphasizing controls, optimization, and interpretation limits.
-
Zoledronic Acid: Cancer and Bone Disease Workflows
2026-09-11
Zoledronic Acid enables connected cancer-cell apoptosis and osteolytic bone disease workflows, rather than a single endpoint screen. This guide translates product characteristics, dose–time testing, and recent pathway-focused research into practical assay design and troubleshooting decisions.
-
ZCL278: Selective Cdc42 Inhibitor Research Guide
2026-09-11
ZCL278 is a selective Cdc42 inhibitor that blocks Cdc42–intersectin signaling and provides a chemical tool for studying cell motility, neuronal morphology, and GTPase-dependent pathways. Product-dossier findings support activity in cancer, neuronal, and fibroblast models, while kidney-fibrosis evidence currently applies to a different Cdc42-targeting molecule.
-
NSC-23766: Translating Rac1 Biology
2026-09-10
A thought-leadership guide to using NSC-23766 trihydrochloride as a mechanistic Rac1 probe, connecting GEF-dependent signaling with breast cancer, endothelial barrier biology, stem cell mobilization, and emerging metabolic insights.
-
Ionomycin Free Acid for Calcium–FAK Studies
2026-09-10
Ionomycin free acid enables controlled calcium ion transport for linking rapid intracellular calcium increase to delayed FAK stability, adhesion, and proteolysis assays. This workflow distinguishes a calcium perturbation tool from a direct FAK inhibitor while extending the FAISL–FAK findings into testable, hypothesis-driven experiments.
-
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-09
RIPA Lysis Buffer (Medium) supports reproducible protein extraction from cultured cells and tissues in extracellular-vesicle cancer studies. Its balanced detergent system and built-in inhibitor set make it practical for Western blotting, pathway validation, and carefully optimized immunoprecipitation workflows.
-
Fungal IAA, DOPE, and Rice Blast Conidial Death
2026-09-09
A 2026 Molecular Plant Pathology study shows that fungus-derived indole-3-acetic acid (IAA) promotes developmental conidial death in Magnaporthe oryzae by connecting lipid metabolism, iron accumulation, lipid peroxidation, and autophagy. Genetic mutants and phosphatidylethanolamine rescue experiments place IAA and PPOA in a pathway that supports ferroptotic death, appressorium formation, and rice blast pathogenicity.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-09-08
Dimethyloxalylglycine (DMOG), SKU A4506, provides a cell-permeable way to investigate pharmacologic hypoxia-inducible factor stabilization and related oxygen-sensing workflows. It is intended for controlled scientific research, including in vitro hypoxia and inflammation studies, and should not be used for diagnostic, clinical, or therapeutic applications.
-
mTORC1 Oscillation Across the Cell Cycle
2026-09-08
The reference study shows that mTORC1 activity is not constant during proliferation: it is lowest in mitosis and G1 and highest during S and G2. This phase-specific pattern supports interphase progression, helps cells satisfy the Chk1/Wee1-dependent G2/M checkpoint, and creates distinct sensitivities to autophagy induction.
-
Temafloxacin: Applied Antibacterial Research Workflows
2026-09-07
Temafloxacin supports practical MIC, time-kill, respiratory, atypical-pathogen, and intracellular infection workflows through dual targeting of bacterial DNA gyrase and topoisomerase IV. This guide connects concentration-controlled bench assays with pharmacokinetic context, troubleshooting, and exposure-aware experimental design.
-
From Mouse Genotype to Macrophage Mechanism
2026-09-07
Translational conclusions are only as strong as the mouse models behind them. This thought-leadership article connects rapid, purification-free genotyping with new evidence that macrophage identity can shift during liver metastasis, offering a strategic framework for model validation, lineage-tracing studies, and reproducible translational research.
-
Dihydrotestosterone Workflows for AR Signaling
2026-09-05
Dihydrotestosterone (DHT) provides a controlled way to activate androgen receptor signaling and interrogate EGFR, ERBB2, AKT, and ERK responses in bladder cancer models. This practical guide also distinguishes established cancer and ALS applications from exploratory extensions into germ-cell assays, with formulation, workflow, and troubleshooting guidance.